Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Epithelial ovarian cancer is predominantly diagnosed at advanced stages which creates significant therapeutic challenges. As a result, the 5-year survival rate is low. Within ovarian cancer, significant tumor heterogeneity exists, and the tumor microenvironment is diverse. Tumor heterogeneity leads...
Saved in:
Main Authors: | Madison Pereira, Kathy Matuszewska, Colin Jamieson, Jim Petrik |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ef36c2a4f82442c6839a11c27f7ad561 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)
by: Viivi Saari, et al.
Published: (2021) -
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
by: Marta Opalińska, et al.
Published: (2021) -
Premature ovarian failure could be an alarming sign of polyglandular autoimmune dysfunction
by: Saif Aasem, et al.
Published: (2017) -
Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
by: Anna Reimer Hansen, et al.
Published: (2021) -
Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers
by: Haixia Song, et al.
Published: (2021)